Healthcare companies rake in $23B in venture capital funding
U.S. healthcare companies have collected $23.4 billion in venture capital funding this year — already surpassing the amount the sector obtained in all of 2017, according to a recent report from Pitchbook, which tracks VC investments. For the healthcare sector, pharmaceuticals and biotechnology amassed the most cash, raking in more than $14 billion in 548 deals through the third quarter of 2018. This is more than they’ve collected in any previous year. Healthcare services and systems raised about $4.3 billion in 376 deals, and healthcare devices and supplies raised about $4.6 billion...
Read MoreUNC, NCSU & Nagoya University team up for agbio, biotech roundtable
An upcoming roundtable in RTP aims to facilitate connections between life science researchers, developers and stakeholders in the Triangle’s academic institutions and that of Nagoya University in Japan. The half-day event features four presentations on a selection of biotech and agtech solutions being developed at Nagoya and in the Triangle. This event is a program of Technology Partnership of Nagoya University (NU Tech), a nonprofit that works to establish technology transfer partnerships between Nagoya University and life science research facilities in North Carolina and other states...
Read MoreNeuroscience: 20 Years Later – A Conversation
Please join us at the SEBIO Investor and Partnering Forum on November 14 for a celebration of our 20th annual conference. We could not think of a better way to mark the 20 years than by being honored with the return of one of most illustrative and long-standing supporters. Max Wallace will moderate a conversation on neuroscience including advances and the future. Joining Max in the conversation will be Marta New of Agent Capital and Donald Lo of the National Center for advancing Translational Sciences (NCATS). Max has served as Chief Executive Officer of Accelerating Brain Cancer August,...
Read MoreSEBIO & PharmaDirections New Award AND EARLY BIRD RATE EXTENDED THROUGH 10/15!!
Get your product development plan for Early-Stage companies for free! The 1st annual JumpStart Grant is being offered by PharmaDirections in partnership with the Southeast BIO Investor and Partnering Forum. The Southeast is only the third of these commitments by PharmaDirections following Pennsylvania, Massachusetts, and California. The investor-ready product development plan will include a detailed GANTT chart with milestones, critical path and itemized budget. Having a detailed, comprehensive and well-conceived development plan is critical to raising venture rounds and executing...
Read MoreGeorgia’s Largest Bioscience Conference Oct. 9!!
There is still time to register! Tuesday, October 9th, Georgia Bio will present the state’s premier bioscience and medtech conference welcoming 500+ CEOs, senior executives, scientists and public policy officials from Georgia and across the nation. This year an exciting program will highlight major trends and issues, including topics related to scientific research, product development, financing, business development and public policy. Do not miss this showcase of Georgia’s leadership in innovation. Visit the website here to view the program and speakers, or download the...
Read MoreMPFI Scientist Wins $6.8 Million NIH Grant For Breakthrough Technique to Map Neuromodulators Within The Brain
JUPITER, FL. – The concept of “finding your happy place” just got a big boost thanks to a Max Planck Florida neuroscientist and the NIH Common Fund. Dr. Hyungbae Kwon, Scientific Group Leader at The Max Planck Florida Institute for Neuroscience has been awarded a 2018 NIH Director’s Pioneer Award for developing a new light-based technique that allows scientists to visualize and map out how emotions affect neurons. While much focus has been placed on studying neuronal connections within the brain, questions about internal brain state remain unanswered. Neurons convey information...
Read More
Follow Us!